1 / 8

Supplemental Figure 1

Supplemental Figure 1. A B. C. Supplemental Figure 2. RWPE-1. DU-145. AR- CaP -M. PC-3. AR- CaP -E. PC-3-ML. 70 kDa. c- myc. 57 kDa. β-actin. 42 kDa. Supplemental Figure 3. A B. Supplemental Figure 4. pPEG -Luc. pAEG -Luc. 24h 48h.

fatima-york
Télécharger la présentation

Supplemental Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Figure 1 AB C

  2. Supplemental Figure 2 RWPE-1 DU-145 AR-CaP-M PC-3 AR-CaP-E PC-3-ML 70 kDa c-myc 57 kDa β-actin 42 kDa

  3. Supplemental Figure 3 A B

  4. Supplemental Figure 4 pPEG-Luc pAEG-Luc 24h 48h 24h 48h D V L R D V L R D V L R D V L R PC3-ML PCa-1 PC3-ML PCa-2 PC3-ML PCa-3 PC3-ML PCa-1 PC3-ML PCa-2 PC3-ML PCa-3 PC3-ML PCa-4 Control Ctrl-1 Control Ctrl-2 Control Ctrl-3 Control Ctrl-1 Control Ctrl-2 Control Ctrl-3

  5. Supplemental Figure 5 NS (Normalized ng Luc pDNA)/(100ng gDNA) AEG-Prom treated PCa Lungs Tumor PEG-Prom treated PCa Lungs Tumor

  6. Supplemental Figure 6 Ex-vivo BLI In-vivo BLI Gross H&E IHC(Anti-Luc) Pathology A B C D E T

  7. Supplemental Figure 7 A B PC3-ML PCa-1 PC3-ML PCa-2 PC3-ML PCa-3 Control Ctrl-1 Control Ctrl-2 Control Ctrl-3

  8. Supplemental Figure 8 B A L2 L2 L1 L2 L5 L3, L4 C

More Related